approval
saveDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 12, 2025 · 296d ago
- approvalDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 12, 2025 · 296d ago
- approvalDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 16, 2024 · 657d ago
- approvalDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalJul 11, 2024 · 815d ago
- approvalDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalJul 11, 2024 · 815d ago
- approvalDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 4, 2020 · 2130d ago
- approvalDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 4, 2020 · 2130d ago
- approvalDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 4, 2020 · 2130d ago
🐶 often sniffed alongside
top 7- drugDEPO-SUBQ PROVERA 104170 co-mentions · 57 sources
- drugDEPO-PROVERA170 co-mentions · 57 sources
- tagApproval110 co-mentions · 55 sources
- drugmedroxyprogesterone60 co-mentions · 57 sources
- companyEugia US LLC7 co-mentions · 2 sources
- tagRecall3 co-mentions · 2 sources
- companyEugia Pharma Specialties Ltd2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that